» Articles » PMID: 34030577

Ensembles in Solution As a New Paradigm for Antibody Structure Prediction and Design

Overview
Journal MAbs
Date 2021 May 25
PMID 34030577
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The rise of antibodies as a promising and rapidly growing class of biotherapeutic proteins has motivated numerous studies to characterize and understand antibody structures. In the past decades, the number of antibody crystal structures increased substantially, which revolutionized the atomistic understanding of antibody functions. Even though numerous static structures are known, various biophysical properties of antibodies (i.e., specificity, hydrophobicity and stability) are governed by their dynamic character. Additionally, the importance of high-quality structures in structure-function relationship studies has substantially increased. These structure-function relationship studies have also created a demand for precise homology models of antibody structures, which allow rational antibody design and engineering when no crystal structure is available. Here, we discuss various aspects and challenges in antibody design and extend the paradigm of describing antibodies with only a single static structure to characterizing them as dynamic ensembles in solution.

Citing Articles

On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.

Fernandez-Quintero M, Guarnera E, Musil D, Pekar L, Sellmann C, Freire F Protein Sci. 2024; 33(11):e5176.

PMID: 39422475 PMC: 11487682. DOI: 10.1002/pro.5176.


Towards the accurate modelling of antibody-antigen complexes from sequence using machine learning and information-driven docking.

Giulini M, Schneider C, Cutting D, Desai N, Deane C, Bonvin A Bioinformatics. 2024; 40(10).

PMID: 39348157 PMC: 11483107. DOI: 10.1093/bioinformatics/btae583.


The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics.

Fischer A, Tichy A, Kokot J, Hoerschinger V, Wild R, Riccabona J J Chem Theory Comput. 2024; 20(5):2321-2333.

PMID: 38373307 PMC: 10938642. DOI: 10.1021/acs.jctc.3c01106.


Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines.

Fernandez-Quintero M, Pomarici N, Fischer A, Hoerschinger V, Kroell K, Riccabona J Antibodies (Basel). 2023; 12(4).

PMID: 37873864 PMC: 10594513. DOI: 10.3390/antib12040067.


Arginine cluster introduction on framework region in anti-lysozyme antibody improved association rate constant by changing conformational diversity of CDR loops.

Maeta S, Nakakido M, Matsuura H, Sakai N, Hirata K, Kuroda D Protein Sci. 2023; 32(9):e4745.

PMID: 37550885 PMC: 10461459. DOI: 10.1002/pro.4745.


References
1.
Chothia C, Lesk A, Tramontano A, Levitt M, AIR G, Sheriff S . Conformations of immunoglobulin hypervariable regions. Nature. 1989; 342(6252):877-83. DOI: 10.1038/342877a0. View

2.
Meyer S, Evers M, Jansen J, Buijs J, Broek B, Reitsma S . New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies. Br J Haematol. 2018; 180(6):808-820. DOI: 10.1111/bjh.15132. View

3.
Sazinsky S, Ott R, Silver N, Tidor B, Ravetch J, Wittrup K . Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc Natl Acad Sci U S A. 2008; 105(51):20167-72. PMC: 2629253. DOI: 10.1073/pnas.0809257105. View

4.
Sotriffer C, Rode B, VARGA J, Liedl K . Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten. Biophys J. 2000; 79(2):614-28. PMC: 1300962. DOI: 10.1016/S0006-3495(00)76320-X. View

5.
Tomlinson I, Cox J, Gherardi E, Lesk A, Chothia C . The structural repertoire of the human V kappa domain. EMBO J. 1995; 14(18):4628-38. PMC: 394555. DOI: 10.1002/j.1460-2075.1995.tb00142.x. View